Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shoulder Joint | 18 | 2024 | 90 | 5.090 |
Why?
|
Rotator Cuff Injuries | 10 | 2022 | 46 | 4.540 |
Why?
|
Rotator Cuff | 11 | 2022 | 44 | 3.410 |
Why?
|
Arthroscopy | 15 | 2022 | 94 | 3.400 |
Why?
|
Joint Diseases | 6 | 2020 | 49 | 2.310 |
Why?
|
Elbow Joint | 4 | 2022 | 34 | 1.650 |
Why?
|
Adrenal Cortex Hormones | 5 | 2023 | 263 | 1.560 |
Why?
|
Orthopedic Procedures | 5 | 2020 | 128 | 1.550 |
Why?
|
Arthroplasty, Replacement | 5 | 2015 | 37 | 1.530 |
Why?
|
Tendon Injuries | 3 | 2022 | 37 | 1.470 |
Why?
|
Surgical Wound Infection | 4 | 2020 | 184 | 1.460 |
Why?
|
Retrospective Studies | 39 | 2022 | 8489 | 1.320 |
Why?
|
Reoperation | 8 | 2021 | 597 | 1.230 |
Why?
|
Arthroplasty, Replacement, Shoulder | 3 | 2021 | 25 | 1.170 |
Why?
|
Shoulder Injuries | 5 | 2020 | 15 | 1.150 |
Why?
|
Injections, Intra-Articular | 6 | 2022 | 27 | 1.110 |
Why?
|
Analgesics, Opioid | 5 | 2020 | 413 | 1.090 |
Why?
|
Bursitis | 2 | 2022 | 11 | 1.010 |
Why?
|
Shoulder | 5 | 2022 | 42 | 1.000 |
Why?
|
Shoulder Dislocation | 3 | 2020 | 16 | 0.980 |
Why?
|
Arthroplasty, Replacement, Hip | 6 | 2022 | 102 | 0.970 |
Why?
|
Joint Instability | 4 | 2020 | 81 | 0.960 |
Why?
|
Knee Joint | 6 | 2022 | 168 | 0.940 |
Why?
|
Spinal Fusion | 6 | 2020 | 85 | 0.900 |
Why?
|
Preoperative Period | 3 | 2020 | 91 | 0.880 |
Why?
|
Arthritis, Rheumatoid | 2 | 2022 | 166 | 0.870 |
Why?
|
Humans | 90 | 2024 | 86643 | 0.870 |
Why?
|
Arthroplasty, Replacement, Knee | 5 | 2022 | 111 | 0.840 |
Why?
|
Shoulder Fractures | 1 | 2021 | 11 | 0.820 |
Why?
|
Tennis Elbow | 1 | 2021 | 13 | 0.810 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2013 | 295 | 0.790 |
Why?
|
Coracoid Process | 2 | 2020 | 3 | 0.780 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 162 | 0.780 |
Why?
|
Tenodesis | 2 | 2020 | 6 | 0.760 |
Why?
|
Diskectomy | 5 | 2020 | 20 | 0.760 |
Why?
|
Current Procedural Terminology | 1 | 2020 | 8 | 0.760 |
Why?
|
Lumbar Vertebrae | 5 | 2020 | 148 | 0.730 |
Why?
|
Radius Fractures | 1 | 2020 | 30 | 0.730 |
Why?
|
Fibula | 1 | 2020 | 32 | 0.730 |
Why?
|
Male | 48 | 2022 | 40965 | 0.720 |
Why?
|
Middle Aged | 40 | 2022 | 25028 | 0.700 |
Why?
|
Postoperative Complications | 10 | 2022 | 2207 | 0.690 |
Why?
|
Aged | 26 | 2022 | 18415 | 0.650 |
Why?
|
Bone Morphogenetic Proteins | 3 | 2016 | 126 | 0.640 |
Why?
|
Humerus | 5 | 2024 | 31 | 0.630 |
Why?
|
Range of Motion, Articular | 9 | 2024 | 154 | 0.630 |
Why?
|
Arthritis, Infectious | 1 | 2017 | 16 | 0.610 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 350 | 0.600 |
Why?
|
Adult | 34 | 2021 | 25648 | 0.600 |
Why?
|
Lacerations | 2 | 2015 | 28 | 0.590 |
Why?
|
Female | 44 | 2022 | 44532 | 0.580 |
Why?
|
Tendon Transfer | 2 | 2020 | 5 | 0.580 |
Why?
|
Patient Care Team | 2 | 2018 | 280 | 0.570 |
Why?
|
Tenocytes | 1 | 2016 | 4 | 0.570 |
Why?
|
Achilles Tendon | 1 | 2016 | 15 | 0.560 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2014 | 85 | 0.550 |
Why?
|
Rupture | 4 | 2022 | 63 | 0.550 |
Why?
|
Patient Acceptance of Health Care | 2 | 2017 | 238 | 0.550 |
Why?
|
Glucocorticoids | 4 | 2023 | 352 | 0.550 |
Why?
|
Family | 1 | 2017 | 311 | 0.550 |
Why?
|
Arthroplasty | 1 | 2015 | 27 | 0.530 |
Why?
|
Treatment Outcome | 13 | 2022 | 7993 | 0.530 |
Why?
|
Databases, Factual | 10 | 2021 | 814 | 0.520 |
Why?
|
Wound Healing | 2 | 2014 | 344 | 0.520 |
Why?
|
Informed Consent | 1 | 2017 | 266 | 0.520 |
Why?
|
Osteoarthritis | 1 | 2015 | 73 | 0.510 |
Why?
|
Cell Differentiation | 9 | 2016 | 1458 | 0.510 |
Why?
|
Platelet-Rich Plasma | 1 | 2014 | 10 | 0.500 |
Why?
|
Communication | 1 | 2018 | 441 | 0.500 |
Why?
|
Osteotomy | 1 | 2014 | 31 | 0.500 |
Why?
|
Ligaments, Articular | 5 | 2022 | 36 | 0.490 |
Why?
|
Growth Differentiation Factor 2 | 5 | 2016 | 152 | 0.480 |
Why?
|
Pain Management | 1 | 2015 | 127 | 0.480 |
Why?
|
Spondylitis, Ankylosing | 4 | 2015 | 24 | 0.480 |
Why?
|
Osteogenesis | 5 | 2016 | 242 | 0.450 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 508 | 0.450 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 636 | 0.450 |
Why?
|
Connective Tissue Diseases | 1 | 2013 | 67 | 0.440 |
Why?
|
Risk Factors | 11 | 2023 | 5417 | 0.440 |
Why?
|
Thymus Gland | 1 | 2013 | 195 | 0.430 |
Why?
|
Osteochondritis Dissecans | 1 | 2012 | 5 | 0.430 |
Why?
|
Acromioclavicular Joint | 2 | 2024 | 5 | 0.430 |
Why?
|
Adipose Tissue | 2 | 2014 | 240 | 0.420 |
Why?
|
Th17 Cells | 2 | 2011 | 80 | 0.410 |
Why?
|
United States | 11 | 2022 | 6672 | 0.400 |
Why?
|
Homeostasis | 1 | 2013 | 409 | 0.400 |
Why?
|
Young Adult | 12 | 2020 | 5976 | 0.390 |
Why?
|
Glycolysis | 1 | 2011 | 129 | 0.380 |
Why?
|
Fractures, Bone | 2 | 2022 | 131 | 0.370 |
Why?
|
Cohort Studies | 7 | 2022 | 2767 | 0.370 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 151 | 0.370 |
Why?
|
Soft Tissue Injuries | 3 | 2014 | 12 | 0.360 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2015 | 2357 | 0.350 |
Why?
|
Debridement | 3 | 2019 | 56 | 0.350 |
Why?
|
Biomechanical Phenomena | 6 | 2024 | 457 | 0.340 |
Why?
|
Pain, Postoperative | 3 | 2020 | 240 | 0.330 |
Why?
|
Obesity | 1 | 2015 | 963 | 0.330 |
Why?
|
Adolescent | 11 | 2020 | 8981 | 0.330 |
Why?
|
HEK293 Cells | 9 | 2016 | 615 | 0.330 |
Why?
|
Joint Prosthesis | 2 | 2011 | 26 | 0.330 |
Why?
|
Comorbidity | 4 | 2021 | 943 | 0.320 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2019 | 74 | 0.310 |
Why?
|
Femoral Fractures | 2 | 2022 | 32 | 0.310 |
Why?
|
Aged, 80 and over | 11 | 2021 | 6509 | 0.310 |
Why?
|
Cerebrospinal Fluid | 1 | 2007 | 32 | 0.310 |
Why?
|
Tendons | 2 | 2020 | 44 | 0.310 |
Why?
|
Scapula | 3 | 2024 | 23 | 0.300 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 1208 | 0.300 |
Why?
|
Blood-Brain Barrier | 1 | 2007 | 70 | 0.300 |
Why?
|
Contracture | 2 | 2020 | 18 | 0.300 |
Why?
|
Magnetic Resonance Imaging | 8 | 2022 | 3362 | 0.290 |
Why?
|
Spinal Fractures | 2 | 2022 | 75 | 0.280 |
Why?
|
Tight Junctions | 1 | 2007 | 149 | 0.280 |
Why?
|
Pharmaceutical Preparations | 1 | 2007 | 92 | 0.280 |
Why?
|
Carrier Proteins | 3 | 2015 | 673 | 0.280 |
Why?
|
Transcription Factors | 1 | 2013 | 1565 | 0.270 |
Why?
|
Antigens, Polyomavirus Transforming | 2 | 2016 | 47 | 0.260 |
Why?
|
Mice | 13 | 2021 | 11352 | 0.260 |
Why?
|
Injections | 2 | 2021 | 109 | 0.250 |
Why?
|
Gene Expression | 3 | 2014 | 1284 | 0.250 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 2 | 2015 | 4 | 0.250 |
Why?
|
Animals | 18 | 2021 | 26582 | 0.250 |
Why?
|
Lumbosacral Region | 3 | 2020 | 25 | 0.250 |
Why?
|
Cervical Vertebrae | 2 | 2019 | 79 | 0.240 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2016 | 273 | 0.240 |
Why?
|
Chondrocytes | 2 | 2014 | 60 | 0.230 |
Why?
|
Odds Ratio | 3 | 2020 | 678 | 0.230 |
Why?
|
DNA Transposable Elements | 2 | 2014 | 169 | 0.230 |
Why?
|
Cartilage, Articular | 2 | 2014 | 67 | 0.230 |
Why?
|
Trigger Finger Disorder | 1 | 2023 | 6 | 0.230 |
Why?
|
Physical Therapy Modalities | 2 | 2022 | 84 | 0.220 |
Why?
|
Triangular Fibrocartilage | 1 | 2022 | 1 | 0.220 |
Why?
|
Radiography | 3 | 2014 | 813 | 0.220 |
Why?
|
Postoperative Period | 2 | 2020 | 303 | 0.220 |
Why?
|
Wrist Joint | 1 | 2022 | 23 | 0.220 |
Why?
|
Logistic Models | 3 | 2020 | 1186 | 0.220 |
Why?
|
Tissue Scaffolds | 2 | 2013 | 106 | 0.210 |
Why?
|
Anesthetics, Local | 2 | 2020 | 76 | 0.210 |
Why?
|
Hip Fractures | 1 | 2022 | 45 | 0.210 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2015 | 302 | 0.210 |
Why?
|
Genetic Predisposition to Disease | 4 | 2015 | 2271 | 0.210 |
Why?
|
Tenosynovitis | 1 | 2021 | 7 | 0.200 |
Why?
|
De Quervain Disease | 1 | 2021 | 7 | 0.200 |
Why?
|
Osteoarthritis, Knee | 1 | 2022 | 63 | 0.200 |
Why?
|
Intervertebral Disc Degeneration | 2 | 2018 | 6 | 0.200 |
Why?
|
Certificate of Need | 1 | 2021 | 3 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 879 | 0.200 |
Why?
|
Cell Line, Transformed | 3 | 2016 | 154 | 0.200 |
Why?
|
Polyradiculopathy | 1 | 2021 | 6 | 0.200 |
Why?
|
Cauda Equina | 1 | 2021 | 13 | 0.200 |
Why?
|
Lymphedema | 1 | 2022 | 77 | 0.190 |
Why?
|
Femoral Neck Fractures | 1 | 2020 | 11 | 0.190 |
Why?
|
Prosthesis-Related Infections | 2 | 2011 | 58 | 0.190 |
Why?
|
Sepsis | 2 | 2017 | 306 | 0.190 |
Why?
|
Trans-Activators | 2 | 2013 | 429 | 0.190 |
Why?
|
Injections, Epidural | 1 | 2020 | 6 | 0.190 |
Why?
|
Steroids | 1 | 2021 | 177 | 0.190 |
Why?
|
New York | 1 | 2020 | 69 | 0.190 |
Why?
|
Low Back Pain | 1 | 2020 | 40 | 0.190 |
Why?
|
Anterior Cruciate Ligament Reconstruction | 1 | 2020 | 18 | 0.190 |
Why?
|
Transplant Donor Site | 1 | 2020 | 3 | 0.190 |
Why?
|
Back Pain | 1 | 2020 | 42 | 0.180 |
Why?
|
Hypertrophy | 1 | 2020 | 62 | 0.180 |
Why?
|
Ankle | 1 | 2020 | 20 | 0.180 |
Why?
|
Femoral Nerve | 1 | 2019 | 7 | 0.180 |
Why?
|
Sciatic Nerve | 1 | 2019 | 33 | 0.180 |
Why?
|
Hip Dislocation, Congenital | 1 | 2019 | 13 | 0.180 |
Why?
|
Foot | 1 | 2020 | 50 | 0.180 |
Why?
|
Ankle Joint | 1 | 2020 | 46 | 0.180 |
Why?
|
Organ Sparing Treatments | 1 | 2019 | 38 | 0.180 |
Why?
|
Surveys and Questionnaires | 2 | 2018 | 2501 | 0.180 |
Why?
|
Aspirin | 1 | 2020 | 156 | 0.170 |
Why?
|
Internal Fixators | 1 | 2019 | 14 | 0.170 |
Why?
|
Mice, Inbred C57BL | 4 | 2016 | 3092 | 0.170 |
Why?
|
Diagnostic Imaging | 2 | 2013 | 469 | 0.170 |
Why?
|
Adenoviridae | 3 | 2015 | 345 | 0.170 |
Why?
|
Health Policy | 1 | 2021 | 180 | 0.170 |
Why?
|
Arthrodesis | 2 | 2021 | 26 | 0.170 |
Why?
|
Hip Dislocation | 1 | 2018 | 10 | 0.170 |
Why?
|
Incidence | 2 | 2021 | 1577 | 0.170 |
Why?
|
Nuclear Proteins | 2 | 2013 | 696 | 0.170 |
Why?
|
Health Care Costs | 1 | 2021 | 238 | 0.170 |
Why?
|
Health Status Indicators | 1 | 2019 | 105 | 0.160 |
Why?
|
Cell Survival | 3 | 2016 | 969 | 0.160 |
Why?
|
Intervertebral Disc Displacement | 1 | 2018 | 24 | 0.160 |
Why?
|
Medicare | 1 | 2022 | 410 | 0.160 |
Why?
|
Decompression, Surgical | 4 | 2021 | 87 | 0.160 |
Why?
|
Allografts | 1 | 2019 | 172 | 0.160 |
Why?
|
Nursing Staff, Hospital | 1 | 2018 | 42 | 0.160 |
Why?
|
Recovery of Function | 2 | 2020 | 272 | 0.160 |
Why?
|
Spinal Diseases | 1 | 2018 | 44 | 0.160 |
Why?
|
Laminectomy | 1 | 2017 | 27 | 0.160 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 153 | 0.160 |
Why?
|
Multivariate Analysis | 1 | 2020 | 999 | 0.160 |
Why?
|
Chemoprevention | 1 | 2018 | 91 | 0.160 |
Why?
|
Follow-Up Studies | 3 | 2014 | 3640 | 0.150 |
Why?
|
Pain Measurement | 2 | 2020 | 321 | 0.150 |
Why?
|
Patient Comfort | 1 | 2017 | 7 | 0.150 |
Why?
|
Training Support | 1 | 2017 | 23 | 0.150 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 916 | 0.150 |
Why?
|
Child | 3 | 2020 | 6927 | 0.150 |
Why?
|
Medical Staff, Hospital | 1 | 2018 | 107 | 0.150 |
Why?
|
Outpatients | 1 | 2017 | 94 | 0.150 |
Why?
|
Thromboembolism | 1 | 2018 | 119 | 0.150 |
Why?
|
Arthrography | 1 | 2016 | 6 | 0.150 |
Why?
|
Chronic Disease | 1 | 2020 | 971 | 0.150 |
Why?
|
Spine | 1 | 2017 | 102 | 0.150 |
Why?
|
Nerve Compression Syndromes | 2 | 2014 | 18 | 0.150 |
Why?
|
Transduction, Genetic | 2 | 2015 | 153 | 0.150 |
Why?
|
Child, Preschool | 2 | 2022 | 3612 | 0.150 |
Why?
|
Body Mass Index | 2 | 2022 | 770 | 0.150 |
Why?
|
Preoperative Care | 2 | 2020 | 397 | 0.150 |
Why?
|
Health Care Surveys | 1 | 2017 | 278 | 0.150 |
Why?
|
Receptors, Interferon | 1 | 2016 | 31 | 0.150 |
Why?
|
Transgenes | 2 | 2014 | 180 | 0.140 |
Why?
|
Models, Anatomic | 1 | 2016 | 91 | 0.140 |
Why?
|
Muscular Atrophy | 2 | 2014 | 41 | 0.140 |
Why?
|
Electromyography | 2 | 2014 | 183 | 0.140 |
Why?
|
Time Factors | 3 | 2020 | 5210 | 0.140 |
Why?
|
CTLA-4 Antigen | 1 | 2016 | 135 | 0.140 |
Why?
|
Benchmarking | 3 | 2023 | 78 | 0.140 |
Why?
|
Operating Rooms | 1 | 2017 | 126 | 0.140 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2016 | 32 | 0.140 |
Why?
|
Intervertebral Disc | 1 | 2015 | 16 | 0.140 |
Why?
|
NIH 3T3 Cells | 1 | 2016 | 105 | 0.140 |
Why?
|
Cell Shape | 1 | 2016 | 51 | 0.140 |
Why?
|
Academic Medical Centers | 1 | 2018 | 379 | 0.130 |
Why?
|
Cell Proliferation | 3 | 2016 | 1578 | 0.130 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 135 | 0.130 |
Why?
|
Femur Head Necrosis | 1 | 2015 | 3 | 0.130 |
Why?
|
Operative Time | 1 | 2015 | 127 | 0.130 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2015 | 26 | 0.130 |
Why?
|
Collagen Type III | 1 | 2014 | 4 | 0.130 |
Why?
|
Signal Transduction | 4 | 2013 | 3241 | 0.130 |
Why?
|
Arthroplasty, Replacement, Elbow | 1 | 2014 | 4 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2014 | 27 | 0.130 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 255 | 0.130 |
Why?
|
Biomarkers | 3 | 2016 | 1718 | 0.130 |
Why?
|
Interferon-gamma | 1 | 2016 | 444 | 0.120 |
Why?
|
Simian virus 40 | 1 | 2014 | 35 | 0.120 |
Why?
|
Chondrogenesis | 1 | 2014 | 26 | 0.120 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 263 | 0.120 |
Why?
|
Multipotent Stem Cells | 1 | 2014 | 19 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2014 | 87 | 0.120 |
Why?
|
Microscopy | 1 | 2014 | 87 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2015 | 1801 | 0.120 |
Why?
|
Cell Line | 4 | 2015 | 2468 | 0.120 |
Why?
|
China | 4 | 2016 | 228 | 0.120 |
Why?
|
Wnt3A Protein | 1 | 2013 | 23 | 0.120 |
Why?
|
Fibronectins | 1 | 2014 | 93 | 0.120 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2013 | 1 | 0.120 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2013 | 5 | 0.120 |
Why?
|
Estrogen Receptor beta | 1 | 2013 | 25 | 0.120 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 937 | 0.120 |
Why?
|
Ribs | 1 | 2013 | 45 | 0.120 |
Why?
|
Treatment Failure | 1 | 2014 | 285 | 0.120 |
Why?
|
Bone Regeneration | 1 | 2013 | 52 | 0.120 |
Why?
|
Neural Conduction | 1 | 2013 | 69 | 0.120 |
Why?
|
Activities of Daily Living | 1 | 2015 | 204 | 0.120 |
Why?
|
Infant | 1 | 2020 | 3046 | 0.120 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 305 | 0.120 |
Why?
|
Humeral Fractures | 1 | 2013 | 16 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2014 | 127 | 0.120 |
Why?
|
Cells, Cultured | 3 | 2013 | 2818 | 0.120 |
Why?
|
Stress, Mechanical | 1 | 2014 | 248 | 0.120 |
Why?
|
Receptor Cross-Talk | 1 | 2013 | 33 | 0.120 |
Why?
|
Osteoblasts | 1 | 2013 | 95 | 0.110 |
Why?
|
Models, Animal | 1 | 2014 | 263 | 0.110 |
Why?
|
Growth Differentiation Factors | 1 | 2013 | 57 | 0.110 |
Why?
|
Epidermal Growth Factor | 1 | 2013 | 119 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 123 | 0.110 |
Why?
|
Chicago | 1 | 2017 | 1379 | 0.110 |
Why?
|
Wnt Signaling Pathway | 1 | 2013 | 91 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 592 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 163 | 0.110 |
Why?
|
Interleukin-2 | 1 | 2013 | 249 | 0.110 |
Why?
|
Opioid-Related Disorders | 3 | 2020 | 161 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2014 | 256 | 0.110 |
Why?
|
Estrogen Receptor alpha | 1 | 2013 | 144 | 0.110 |
Why?
|
Polyesters | 2 | 2013 | 41 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 407 | 0.110 |
Why?
|
Melanoma | 1 | 2016 | 459 | 0.110 |
Why?
|
beta Catenin | 1 | 2013 | 251 | 0.110 |
Why?
|
Bone Cements | 1 | 2011 | 9 | 0.100 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 250 | 0.100 |
Why?
|
Up-Regulation | 1 | 2014 | 712 | 0.100 |
Why?
|
Skin Neoplasms | 1 | 2016 | 546 | 0.100 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2011 | 17 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 1219 | 0.100 |
Why?
|
Flow Cytometry | 1 | 2013 | 679 | 0.100 |
Why?
|
Mice, Knockout | 2 | 2013 | 1924 | 0.100 |
Why?
|
Arm | 2 | 2022 | 91 | 0.100 |
Why?
|
Candidiasis | 1 | 2011 | 36 | 0.100 |
Why?
|
Analysis of Variance | 1 | 2013 | 912 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 57 | 0.100 |
Why?
|
Stem Cells | 1 | 2013 | 351 | 0.100 |
Why?
|
Fibroblasts | 1 | 2014 | 729 | 0.100 |
Why?
|
Prospective Studies | 2 | 2019 | 4213 | 0.100 |
Why?
|
Genetic Therapy | 1 | 2013 | 342 | 0.100 |
Why?
|
Listeriosis | 1 | 2011 | 84 | 0.100 |
Why?
|
Bone Nails | 1 | 2010 | 17 | 0.100 |
Why?
|
Fractures, Open | 1 | 2010 | 11 | 0.100 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2010 | 15 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2024 | 579 | 0.090 |
Why?
|
DNA Primers | 1 | 2011 | 543 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 166 | 0.090 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 1376 | 0.090 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 1991 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 178 | 0.090 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 1673 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 182 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2011 | 746 | 0.090 |
Why?
|
Thoracic Injuries | 1 | 2009 | 32 | 0.080 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 49 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2022 | 2903 | 0.080 |
Why?
|
Absorbable Implants | 1 | 2008 | 34 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2011 | 425 | 0.080 |
Why?
|
Internship and Residency | 1 | 2017 | 1004 | 0.080 |
Why?
|
Choroid Plexus | 1 | 2007 | 14 | 0.080 |
Why?
|
Claudin-1 | 1 | 2007 | 17 | 0.080 |
Why?
|
Occludin | 1 | 2007 | 66 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2011 | 1540 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2007 | 134 | 0.080 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2007 | 70 | 0.080 |
Why?
|
Base Sequence | 1 | 2011 | 2330 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 307 | 0.070 |
Why?
|
Biological Transport | 1 | 2007 | 396 | 0.070 |
Why?
|
Prosthesis Design | 1 | 2007 | 278 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2007 | 254 | 0.070 |
Why?
|
In Vitro Techniques | 1 | 2007 | 989 | 0.070 |
Why?
|
Genotype | 3 | 2015 | 1851 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 859 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2014 | 1805 | 0.060 |
Why?
|
Acromion | 1 | 2024 | 3 | 0.060 |
Why?
|
Cell Separation | 2 | 2014 | 196 | 0.060 |
Why?
|
Alkaline Phosphatase | 2 | 2013 | 132 | 0.060 |
Why?
|
Choristoma | 2 | 2013 | 68 | 0.060 |
Why?
|
Gene Silencing | 2 | 2014 | 172 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2007 | 669 | 0.060 |
Why?
|
Gene Transfer Techniques | 2 | 2014 | 152 | 0.060 |
Why?
|
Ulna | 1 | 2022 | 13 | 0.050 |
Why?
|
Acetabulum | 1 | 2022 | 28 | 0.050 |
Why?
|
Ligaments | 1 | 2022 | 32 | 0.050 |
Why?
|
Extracellular Matrix | 2 | 2014 | 232 | 0.050 |
Why?
|
Cadaver | 1 | 2022 | 185 | 0.050 |
Why?
|
Genetic Vectors | 2 | 2014 | 439 | 0.050 |
Why?
|
Hyaluronic Acid | 1 | 2022 | 49 | 0.050 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 246 | 0.050 |
Why?
|
Femur | 1 | 2022 | 116 | 0.050 |
Why?
|
Linkage Disequilibrium | 2 | 2013 | 473 | 0.050 |
Why?
|
Hospitalization | 2 | 2019 | 849 | 0.050 |
Why?
|
Drainage | 1 | 2022 | 157 | 0.050 |
Why?
|
Rats | 1 | 2007 | 3990 | 0.050 |
Why?
|
Insurance Claim Review | 1 | 2020 | 41 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2007 | 1196 | 0.050 |
Why?
|
Finite Element Analysis | 1 | 2020 | 74 | 0.050 |
Why?
|
Bone Screws | 1 | 2020 | 44 | 0.050 |
Why?
|
Tissue Adhesions | 1 | 2020 | 50 | 0.050 |
Why?
|
Alleles | 2 | 2014 | 1128 | 0.050 |
Why?
|
Anterior Cruciate Ligament Injuries | 1 | 2020 | 40 | 0.050 |
Why?
|
Cytokines | 2 | 2016 | 776 | 0.050 |
Why?
|
Fracture Fixation, Internal | 1 | 2020 | 66 | 0.050 |
Why?
|
Trauma, Nervous System | 1 | 2019 | 6 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2020 | 78 | 0.040 |
Why?
|
Hip Joint | 1 | 2019 | 55 | 0.040 |
Why?
|
Elective Surgical Procedures | 1 | 2020 | 116 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2019 | 109 | 0.040 |
Why?
|
Regeneration | 1 | 2020 | 143 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 331 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2021 | 246 | 0.040 |
Why?
|
Betamethasone | 1 | 2018 | 5 | 0.040 |
Why?
|
Humeral Head | 1 | 2018 | 7 | 0.040 |
Why?
|
Oxycodone | 1 | 2018 | 35 | 0.040 |
Why?
|
Anesthesia | 1 | 2020 | 164 | 0.040 |
Why?
|
Joint Dislocations | 1 | 2018 | 27 | 0.040 |
Why?
|
Hip Prosthesis | 1 | 2018 | 34 | 0.040 |
Why?
|
Lidocaine | 1 | 2018 | 63 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2018 | 119 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2019 | 238 | 0.040 |
Why?
|
Drug Combinations | 1 | 2018 | 224 | 0.040 |
Why?
|
Family Relations | 1 | 2017 | 35 | 0.040 |
Why?
|
Anticoagulants | 1 | 2020 | 408 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 102 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 222 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 996 | 0.040 |
Why?
|
Ipilimumab | 1 | 2016 | 58 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2019 | 243 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 103 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2017 | 170 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 236 | 0.030 |
Why?
|
Quality Improvement | 1 | 2019 | 428 | 0.030 |
Why?
|
Patient Readmission | 1 | 2019 | 329 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2015 | 66 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 339 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 104 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 2015 | 8 | 0.030 |
Why?
|
Subcutaneous Tissue | 1 | 2014 | 10 | 0.030 |
Why?
|
Cell Aggregation | 1 | 2014 | 39 | 0.030 |
Why?
|
Antigens, Viral, Tumor | 1 | 2014 | 15 | 0.030 |
Why?
|
Tennis | 1 | 2014 | 3 | 0.030 |
Why?
|
Fibrocartilage | 1 | 2014 | 1 | 0.030 |
Why?
|
Integrases | 1 | 2014 | 59 | 0.030 |
Why?
|
Acetylation | 1 | 2014 | 121 | 0.030 |
Why?
|
Arthralgia | 1 | 2014 | 36 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 22 | 0.030 |
Why?
|
Homologous Recombination | 1 | 2014 | 51 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 207 | 0.030 |
Why?
|
Durapatite | 1 | 2013 | 28 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2016 | 1014 | 0.030 |
Why?
|
Bone Matrix | 1 | 2013 | 18 | 0.030 |
Why?
|
Muscle Weakness | 1 | 2014 | 61 | 0.030 |
Why?
|
Smad Proteins | 1 | 2013 | 39 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2013 | 33 | 0.030 |
Why?
|
Collagen Type I | 1 | 2013 | 62 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2014 | 268 | 0.030 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 582 | 0.030 |
Why?
|
Calcium Phosphates | 1 | 2013 | 77 | 0.030 |
Why?
|
Contrast Media | 1 | 2018 | 1078 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2015 | 294 | 0.030 |
Why?
|
Lactic Acid | 1 | 2013 | 90 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2014 | 207 | 0.030 |
Why?
|
Estradiol | 1 | 2013 | 252 | 0.030 |
Why?
|
Estrogens | 1 | 2013 | 200 | 0.030 |
Why?
|
Electrodiagnosis | 1 | 2012 | 7 | 0.030 |
Why?
|
Fetus | 1 | 2013 | 226 | 0.030 |
Why?
|
Extremities | 1 | 2013 | 167 | 0.030 |
Why?
|
Rabbits | 1 | 2013 | 636 | 0.030 |
Why?
|
Histones | 1 | 2014 | 311 | 0.030 |
Why?
|
Acrylates | 1 | 2011 | 19 | 0.030 |
Why?
|
Gene Frequency | 1 | 2014 | 677 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 1621 | 0.030 |
Why?
|
Polymers | 1 | 2013 | 202 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 610 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2011 | 4 | 0.030 |
Why?
|
STAT4 Transcription Factor | 1 | 2011 | 10 | 0.030 |
Why?
|
Mice, Nude | 1 | 2013 | 790 | 0.030 |
Why?
|
Inpatients | 1 | 2014 | 297 | 0.020 |
Why?
|
Haplotypes | 1 | 2013 | 642 | 0.020 |
Why?
|
Length of Stay | 1 | 2014 | 702 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2011 | 78 | 0.020 |
Why?
|
Physical Examination | 1 | 2012 | 149 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 115 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2011 | 168 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 439 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2012 | 151 | 0.020 |
Why?
|
Quality of Life | 1 | 2019 | 1585 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2010 | 34 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 2426 | 0.020 |
Why?
|
Cell Communication | 1 | 2011 | 194 | 0.020 |
Why?
|
Th1 Cells | 1 | 2011 | 164 | 0.020 |
Why?
|
ErbB Receptors | 1 | 2013 | 485 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2016 | 1195 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2011 | 164 | 0.020 |
Why?
|
Trauma Centers | 1 | 2010 | 116 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 243 | 0.020 |
Why?
|
DNA Methylation | 1 | 2014 | 628 | 0.020 |
Why?
|
Kyphosis | 1 | 2009 | 14 | 0.020 |
Why?
|
Sheep, Domestic | 1 | 2008 | 6 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2011 | 409 | 0.020 |
Why?
|
Phenotype | 1 | 2014 | 2378 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 2601 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 1920 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 2261 | 0.010 |
Why?
|